Present Status and Future Prospects for Adjuvant Therapy of Melanoma: Time to Build upon the Foundation of High-dose Interferon Alfa-2b The high cure rates for patients with Hodgkin's Disease (HD) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results